Chembio Terminates US Distribution Agreement with Alere
Chembio Diagnostics has announced plans to build a US sales and marketing team after notifying Alere of the termination of its US Stat-Pak distribution agreement.
Read MorePosted by Steve Halasey | Apr 7, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, Sexually Transmitted Diseases |
Chembio Diagnostics has announced plans to build a US sales and marketing team after notifying Alere of the termination of its US Stat-Pak distribution agreement.
Read MorePosted by Steve Halasey | Mar 18, 2014 | Molecular Diagnostics |
At the beginning of April, FDA will host a public workshop on “Advancing Regulatory Science for High-Throughput Sequencing Devices for Microbial Identification and Detection of Antimicrobial Resistance Markers.”
Read MorePosted by Clinical Lab Products | Mar 11, 2014 |
The number of pharma-Dx partnering agreements is growing by leaps and bounds. Here’s a brief summary of some recent agreements announced by CLP and other news services: Adaptive Biotechnologies According to company sources,...
Read MorePosted by Steve Halasey | Mar 11, 2014 | Molecular Diagnostics |
Genomics tools company RainDance Technologies has closed a $16.5 million financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in the round.
Read MorePosted by Steve Halasey | Feb 4, 2014 | Research |
Researchers at the National Institutes of Health have analyzed results from 20 years of research on people with autoimmune lymphoproliferative syndrome. Their report describes an easy-to-measure biomarker and strategies to improve treatment.
Read More